发布: 2018年01月20日第8卷第2期 DOI: 10.21769/BioProtoc.2698 浏览次数: 7225
评审: Pengpeng LiSalome Calado BotelhoJingli Cao
Abstract
D-serine is an atypical amino acid present in the mammalian body (most amino acids in the mammalian body are L-isomers) that is mostly known in neuroscience for its role as a co-agonist controlling the N-methyl D-aspartate receptor (NMDAR). D-serine levels are decreased in patients with schizophrenia and this is thought to mediate, at least in part, the hypofunction of NMDARs that is central to the glutamate hypothesis for the etiology of this neuropsychiatric disorder. D-serine detection was first established using high performance liquid chromatography, a costly and complex technique that requires high levels of expertise. But with the increasing interest in this unconventional amino acid, there is an increasing need for easier, cheaper and more accessible detection methods. Here we describe the amperometric, biosensor-based method we employed in a recent publication (Papouin et al., 2017b). It allows reliable measurement of D-serine levels from fresh tissue, such as acute brain slices, for concentrations higher than 100 nM, with minimal technical requirements.
Keywords: D-serine (D-丝氨酸)Background
The N-methyl D-aspartate receptor (NMDAR) is a receptor for the neurotransmitter glutamate in the brain, spinal cord and in the peripheral nervous system such as enteric neurons. It is also found in renal tubular cells and chondrocytes. In addition to glutamate, the activation of the NMDAR requires the binding of a co-agonist on a dedicated binding site (Johnson and Ascher, 1987; Kleckner and Dingledine, 1988). The unconventional amino acid D-serine is the endogenous co-agonist of the NMDAR in numerous regions of the nervous system (see Papouin et al., 2017a). It is also found abundantly in the liver and kidneys where its degradation and excretion take place (Montesinos Guevara and Mani, 2016). D-serine is also found in the gut, where its function and origin (host metabolite or bacterial origin) are unclear. Therefore, detecting and measuring D-serine levels has become necessary in several subfields of neuroscience and other disciplines but has proven technically challenging. In the brain and spinal cord, assessing the occupancy of the NMDAR co-agonist binding site is an excellent first approach to assess D-serine levels (Papouin et al., 2012; Papouin et al., 2017b; Ferreira et al., 2017). However, major limitations of this approach are that 1) it provides little quantitative insights into the actual concentration of D-serine, 2) it is subject to a strong ceiling effect (once the co-agonist binding site is saturated, higher levels of D-serine go undetected), 3) glycine can also bind to the NMDAR co-agonist binding site and compete with D-serine, 4) this approach is subject to changes and differences in the affinity of the NMDAR co-agonist binding site, and finally 5) this method is only useful in conditions where recording NMDAR activity is technically possible. Therefore, obtaining direct measurements of D-serine has become a necessity and challenge. Two methods are currently available. The first one is electrophoresis-based, in particular high performance liquid chromatography (Papouin et al., 2017b) or capillary electrophoresis (Ferreira et al., 2017) which has been amply documented. While they provide high levels of precision and reliability, they also require expensive equipment and extensive technical expertise. The second one is based on the use of biosensors such as those developed by Sarissa (Dale et al., 2005) or by several independent labs such as Pernot et al., 2008, which requires minimal equipment or technical expertise. Biosensors usually consist of probes coated with the enzyme D-amino acid oxidase which degrades D-serine to produce electrons. They function as amperometric probes, where electrical current produced during D-serine degradation is used to measure the amount of D-serine present. We found that the use of sensors comes with pitfalls and caveats that, if not carefully avoided or controlled, can lead to aberrant measurements. Therefore, in a recent study (Papouin et al., 2017b) we developed a protocol to reliably detect D-serine levels in brain slices using D-serine biosensors from Sarissa. Here, we describe this protocol in greater detail, and in a step-by-step manner. This protocol is based on obtaining conditioned medium from brain slices and, therefore, can be easily adapted to any tissue of interest, such as the spinal cord, kidney or liver, provided that acute slices can be obtained.
Materials and Reagents
Materials
Reagents
Equipment
Software
Procedure
文章信息
版权信息
© 2018 The Authors; exclusive licensee Bio-protocol LLC.
如何引用
Papouin, T. and Haydon, P. G. (2018). D-serine Measurements in Brain Slices or Other Tissue Explants. Bio-protocol 8(2): e2698. DOI: 10.21769/BioProtoc.2698.
分类
神经科学 > 细胞机理 > 突触生理学
您对这篇实验方法有问题吗?
在此处发布您的问题,我们将邀请本文作者来回答。同时,我们会将您的问题发布到Bio-protocol Exchange,以便寻求社区成员的帮助。
提问指南
+ 问题描述
写下详细的问题描述,包括所有有助于他人回答您问题的信息(例如实验过程、条件和相关图像等)。
Share
Bluesky
X
Copy link